Advances in personalised therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivity
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Keyword(s):
Keyword(s):